PI3K in Stemness Regulation: From Development to Cancer (2019)
Attributed to:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20944/preprints201911.0170.v1
Publication URI: http://dx.doi.org/10.20944/preprints201911.0170.v1
Type: Preprint